Dana VanBuecken, ARNP, Research Nurse Practitioner, shares why she encourages families to participate in TrialNet

We want to extend our gratitude to all of our TrialNet families. Whether you joined us this month or have been involved for years, thank you for making the decision to participate. You are the most important part of our research team.

Jordan Morris is a Major League Soccer player for the Seattle Sounders FC & U.S. Men's National team who has also been living with type 1 diabetes since age 9.

When Jadah Schuh first heard about TrialNet screening at a JDRF Walk, she wanted to do it, but there was one problem: the blood draw. Several years and JDRF Walks would go by before, at age 8, she finally got screened at Camp Needlepoint, where her brother, Travis, was attending a T1D camp.

Like many parents, AJ & Emily Eyth were worried about their daughters’ risk to develop type 1 diabetes because AJ lives with the disease. They learned about the TrialNet Pathway to Prevention risk screening offered at the University of South Florida and decided to enroll their daughters, Kacie & Kaley.

Bridget Montgomery’s introduction to type 1 diabetes was when her son, Clifford, was diagnosed in DKA at the age of 6. It was at their initial type 1 diabetes training through Children’s Hospital of Pittsburgh that she learned about the opportunity to participate in TrialNet.

Elliot, a 17-year-old from a small village outside Bristol, recently completed treatment in the Abatacept Prevention Study. He is the first person in the United Kingdom (UK) to do so.

For the Loving family, knowledge is power, and they are forever grateful for TrialNet.